These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18631754)

  • 21. Influence of white matter hyperintensities on the cognition of patients with Parkinson disease.
    Lee SJ; Kim JS; Yoo JY; Song IU; Kim BS; Jung SL; Yang DW; Kim YI; Jeong DS; Lee KS
    Alzheimer Dis Assoc Disord; 2010; 24(3):227-33. PubMed ID: 20473133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Kulisevsky J
    Neurobiol Dis; 2012 Jun; 46(3):590-6. PubMed ID: 22484304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia.
    Benninger D; Waldvogel D; Bassetti CL
    Neurology; 2008 Sep; 71(12):955; author reply 955-6. PubMed ID: 18794502
    [No Abstract]   [Full Text] [Related]  

  • 24. Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease.
    Bronnick K; Emre M; Tekin S; Haugen SB; Aarsland D
    Mov Disord; 2011 Apr; 26(5):824-9. PubMed ID: 21437985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cognitive and neuropsychiatric disorders in Parkinson's disease].
    Rodríguez-Constenla I; Cabo-López I; Bellas-Lamas P; Cebrián E
    Rev Neurol; 2010 Feb; 50 Suppl 2():S33-9. PubMed ID: 20205140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs to treat dementia and psychosis: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S120-7. PubMed ID: 12211152
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neuropsychological characteristics of Parkinson's disease].
    Ostrosky-Solis F
    Rev Neurol; 2000 Apr 16-30; 30(8):788-96. PubMed ID: 10893746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dementia and psychiatric disorders of Parkinson disease and their physiopathology].
    Tamaru F
    Nihon Naika Gakkai Zasshi; 1994 Apr; 83(4):555-8. PubMed ID: 7963989
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuropsychological disturbances and cerebral atrophy determined by computerized tomography in parkinsonian patients with long-term levodopa treatment.
    Portin R; Raininko R; Rinne UK
    Adv Neurol; 1984; 40():219-27. PubMed ID: 6695598
    [No Abstract]   [Full Text] [Related]  

  • 30. SCOPA-cognition cutoff value for detection of Parkinson's disease dementia.
    Verbaan D; Jeukens-Visser M; Van Laar T; van Rooden SM; Van Zwet EW; Marinus J; van Hilten JJ
    Mov Disord; 2011 Aug; 26(10):1881-6. PubMed ID: 21542025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
    Goetz CG; Emre M; Dubois B
    Ann Neurol; 2008 Dec; 64 Suppl 2():S81-92. PubMed ID: 19127578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apathy may herald cognitive decline and dementia in Parkinson's disease.
    Dujardin K; Sockeel P; Delliaux M; Destée A; Defebvre L
    Mov Disord; 2009 Dec; 24(16):2391-7. PubMed ID: 19908317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson-related dementias.
    Boeve BF
    Neurol Clin; 2007 Aug; 25(3):761-81, vii. PubMed ID: 17659189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Parkinson disease and cognition].
    Kulisevsky J; Pascual-Sedano B
    Neurologia; 1999 May; 14 Suppl 1():72-81. PubMed ID: 10377731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's disease with dementia, lewy-body disorders and alpha-synuclein: recent advances and a case report.
    Wu CK
    Acta Neurol Taiwan; 2011 Mar; 20(1):4-14. PubMed ID: 21560084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mental disorders in Parkinson's disease.
    Rafal R
    R I Med J (1976); 1986 Jul; 69(7):323-6. PubMed ID: 3462889
    [No Abstract]   [Full Text] [Related]  

  • 37. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Parkinson syndrome and cognitive disorders].
    Szirmai I; Kovács T
    Ideggyogy Sz; 2002 Jul; 55(7-8):220-5. PubMed ID: 12201229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.
    Kasten M; Bruggemann N; Schmidt A; Klein C
    Neurology; 2010 Aug; 75(5):478; author reply 478-9. PubMed ID: 20679642
    [No Abstract]   [Full Text] [Related]  

  • 40. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia.
    Song IU; Kim JS; Jeong DS; Song HJ; Lee KS
    Parkinsonism Relat Disord; 2008 Nov; 14(7):558-62. PubMed ID: 18328767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.